Cite
HARVARD Citation
Atri, A. et al. (n.d.). P1‐056: Idalopirdine, A 5‐HT6 Antagonist in Phase III Development as Adjunctive Therapy to Cholinesterase Inhibitors in Patients with Mild‐to‐Moderate Alzheimer's Disease: Baseline Data from the Ongoing Starshine Study. Alzheimer's & dementia. p. P423. [Online].